As CML is characterized by the presence of the BCR-ABL protein, we reasoned that the abnormal expression of these 3 miRNAs observed in the CML patient could be dependent on the kinase activity of BCR-ABL. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.